---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-25-000376"
form_type: "8-K"
ticker: "PTHS"
cik: "0001919246"
company_name: "Pelthos Therapeutics Inc."
filed_at: "2025-03-03T23:59:59+00:00"
generated_at: "2026-05-25T21:14:20.843177+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Channel Therapeutics issues $325K promissory note to 3i, L.P. at $250K purchase price

## Summary
- Issued $325,000 principal unsecured note to 3i, L.P. for $250,000 purchase price (approx. 23% discount).
- Interest at 6.0% simple p.a.; maturity on May 25, 2025 or upon Corporate Event or default.
- Prepayable without penalty on 2 days' notice; proceeds for general working capital.
- Note is unsecured; contains standard Events of Default and no stockholder rights.

## SEC filing metadata
- accession: 0001753926-25-000376
- form_type: 8-K
- ticker: PTHS
- cik: 0001919246
- company_name: Pelthos Therapeutics Inc.
- filed_at: 2025-03-03T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1919246/000175392625000376/0001753926-25-000376-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1919246/000175392625000376/g084719_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-25-000376
- JSON: https://secwatch.observer/filing/0001753926-25-000376.json
- Plain text: https://secwatch.observer/filing/0001753926-25-000376.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.